Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuromuscular
When do you utilize rozanolixizumab in patients with myasthenia gravis?
Related Questions
Should IVIG dosing in patients with autoimmune disease (i.e., dermatomyositis) who become pregnant continue to be based on actual weight at the time of each infusion, or should it be limited to pre-pregnancy weight?
How do you use muscle MRI in the diagnosis and management of muscular dystrophies?
How do you track objective clinical response to treatment in CIDP?
How do you approach patients with positive LRP4 antibodies without clinical findings of myasthenia gravis?
Is measuring total IgG levels during acute myasthenia gravis exacerbations helpful for monitoring treatment or guiding the number of plasma exchange procedures?
In which clinical scenarios do you find medial and lateral plantar sensory or mixed nerve conduction studies to be valuable?
Would you add immunosuppression in ocular myasthenia gravis patients who are symptomatically well-controlled on pyridostigmine?
How do you counsel newly diagnosed patients with ALS on dietary recommendations?
What is the stepwise investigation of patients suspected of inflammatory myopathy?
How do you counsel patients who wish to travel to high altitudes with myasthenia gravis?
